Results 131 to 140 of about 27,152 (233)

MELAS‐Like Mitochondrial Encephalopathy With Catatonia Associated With a Pathogenic MT‐ND3 (m.10158 T > C) Mutation: A Case Report and Literature Review

Progress in Neurology and Psychiatry, Volume 30, Issue 2, May 2026.
Abstract Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke‐like episodes (MELAS) is a rare multisystem mitochondrial disorder primarily caused by mutations in mitochondrial DNA. While it typically presents with stroke‐like episodes, seizures, and lactic acidosis, recent evidence highlights a broader clinical spectrum, including ...
Faezeh Khorshidian, Vajiheh Aghamollaii, Mohammadreza Mousavipour, Setareh Rassa   +3 more
wiley   +1 more source

The relationship between the cannabinoids and cardiac remodelling: A comprehensive review of pivotal mechanisms and emerging evidence

British Journal of Pharmacology, Volume 183, Issue 9, Page 1747-1778, May 2026.
Cardiac remodelling and fibrosis after myocardial infarction or during chronic diseases, such as arterial and pulmonary hypertension or diabetes mellitus, continue to be the more important prognostic factors in determining survival, and so the search for effective anti‐fibrotic interventions is an important target for research and therapy in cardiology.
Anna Krzyżewska, Marta Baranowska‐Kuczko, Hanna Kozłowska   +2 more
wiley   +1 more source

Chronic Kidney Disease‐Associated Pruritus in Patients on Home Haemodialysis

Nephrology, Volume 31, Issue 5, May 2026.
ABSTRACT Aim Chronic kidney disease‐associated pruritus is a common and distressing symptom in people with chronic kidney disease and is linked to increased mortality. Home haemodialysis is associated with a number of benefits compared to centre‐based haemodialysis. However, the impact of chronic kidney disease‐associated pruritus in patients receiving
Kavana Krishna Nayak, Jing Xin Goh, Kamal Sud, Surjit Tarafdar, Linda Le Do, Nazim Bhimani, Girish Thunga, Ronald L. Castelino   +7 more
wiley   +1 more source

Assessment of Within- and Inter-Patient Variability of Uremic Toxin Concentrations in Children with CKD

Toxins
To promote improved trial design in upcoming randomized clinical trials in childhood chronic kidney disease (CKD), insight in the within- and inter-patient variability of uremic toxins with its nutritional, treatment- and patient-related confounding ...
Evelien Snauwaert, Stefanie De Buyser, An Desloovere, Wim Van Biesen, Ann Raes, Griet Glorieux, Laure Collard, Koen Van Hoeck, Maria Van Dyck, Nathalie Godefroid, Johan Vande Walle, Sunny Eloot   +11 more
doaj   +1 more source

Augmented Cardiopulmonary Baroreflex Sensitivity in Intradialytic Hypertension. [PDF]

, 2018
IntroductionEnd-stage renal disease (ESRD) patients with a paradoxical increase in blood pressure (BP) during hemodialysis (HD), termed intradialytic hypertension (ID-HTN), are at significantly increased risk for mortality and adverse cardiovascular ...
DaCosta, Dana R, Fonkoue, Ida T, Li, Yunxiao, Middlekauff, Holly R, Park, Jeanie, Park, Sook H   +5 more
core  

Haptoglobin genotypes, inflammation status and their associations with hemoglobin levels in stage 4 chronic kidney disease patients with anemia [PDF]

Background and aims: Anemia and increased inflammation are the main causes of mortality in chronic kidney disease (CKD) patients. This study was designed to explore the probable relationship of hemoglobin (Hb) with serum haptoglobin (HP), its ...
ارگانی, حسن, حسینی اصل, سید سعید, علی پناه مقدم, رضا, قربانی حق جو, امیر   +3 more
core  

Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies [PDF]

, 2008
Glorieux, Griet, Van Biesen, Wim, VAN LAECKE, STEVEN, Vanholder, Raymond, Verbeke, Francis   +4 more
core   +1 more source

Effect of hemoperfusion plus hemodialysis on uremic toxins and anemia in patients with maintenance hemodialysis. [PDF]

Ren Fail
Zou LX, Wang X, Qian CH, Zheng XQ, Sun L.   +4 more
europepmc   +1 more source

[Uremic toxins].

Nihon rinsho. Japanese journal of clinical medicine, 1978
S, Nakagawa, M, Suenaga
  +6 more sources

Strategies for Removal of Protein-Bound Uremic Toxins in Hemodialysis. [PDF]

Toxins (Basel)
de Vries JC, Brás JG, de Vries GM, Vollenbroek JC, Wieringa FP, Jankowski J, Verhaar MC, Stamatialis D, Masereeuw R, Gerritsen KGF.   +9 more
europepmc   +1 more source